EFFECT OF BETA-ENDORPHIN ON HUMAN CHORIONIC-GONADOTROPIN SECRETION BY PLACENTAL EXPLANTS

被引：11

作者：

BARNEA, ER

ASHKENAZY, R

TAL, Y

KOL, S

SARNE, Y

机构：

[1] University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Fertility, Camden, NJ

[2] Feto-Placental Endocrine Unit, Rappaport Institute Technion, Rh Efron, Haifa

[3] Department of Physiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv

来源：

HUMAN REPRODUCTION | 1991年 / 6卷 / 09期

关键词：

BETA ENDORPHIN; HCG; INVITRO; PLACENTA;

D O I：

10.1093/oxfordjournals.humrep.a137534

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

In the present study the effect of physiological concentrations of beta-endorphin was examined upon human chorionic gonadotrophin (HCG) secretion by first trimester placental explants. Results show that at 7-9 weeks of gestation, beta-endorphin inhibited HCG secretion; a maximal suppression of 60% was noted at 5 X 10(-10) M concentrations, while fivefold lower or higher doses were less effective. This inhibitory effect was completely reversed by naloxone, an opiate receptor antagonist, indicating involvement of an opiate receptor in the action of beta-endorphin. The opioid peptide specificity was demonstrated by the failure of N-acetyl-beta-endorphin, a non-opiate analogue used at the same concentration range, to affect HCG secretion. Following the HCG peak, at 11 weeks however, the effect of beta-endorphin was stimulatory on HCG secretion, which suggests a gestational age-dependent effect of the opioid peptide. In conclusion, these data indicate that beta-endorphin, a mu and delta-opioid receptor ligand, has a modulatory effect on HCG secretion in vitro in the young placenta.

引用

页码：1327 / 1331

页数：5

共 20 条

[1]

Ahmed M.S., Randall L.W., Sibai B., Dass C., Fridland G., Desiderio D.M., Tolun E., Identification of dynorphin 1-8 in human placenta by mass spectrometry, Life Sci., 40, pp. 2067-2076, (1987)

[2]

Bamea E.R., Fakih H., The role of catechol estrogens in placental steroidogenesis, Steroids, 45, pp. 427-432, (1985)

[3]

Bamea E.R., Kaplan M., Spontaneous, gonadotrophinreleasing hormone-induced, and progesterone-inhibited pulsatile secretion of human chorionic gonadotropin in the first trimester placenta in vitro, J. Clin. Endocrinol. Metab., 69, pp. 215-217, (1989)

[4]

Bamea E.R., Tal Y., Stress related reproductive failure, J. in Vitro Fertil. Embryo Transfer, 8, pp. 17-25, (1991)

[5]

Bamea E.R., Feldman D., Kaplan M., Morrish D.W., The dual effect of epidermal growth factor upon human chorionic gonadotropin secretion by the first trimester placenta in vitro, J. Clin. Endocrinol. Metab., 71, pp. 923-928, (1990)

[6]

Bamea E.R., Ashkenazi R., Same Y., The effect of dynorphin on placental pulsatile hCG secretion in vitro, J. Clin. Endocrinol. Metab., 73, pp. 1093-1098, (1991)

[7]

Bamea E.R., Feldman D., Shurtz-Swirsky R., Kaplan M., Gestational age dependent, rapid and delayed effect of epidermal growth factor upon human chorionic gonadotropin secretion by the first trimester explants, Troph. Res, 6, (1991)

[8]

Cemerikic B., Genbacev O., Sulovic V., Beaconsfield R., Effect of morphine on hCG release by first trimester human trophoblast in vitro, Life Sci., 42, pp. 1773-1779, (1988)

[9]

Fakih M.H., Bamea E.R., Yarkoni S., Dechemey A.H., The value of real time sonography in first trimester termination, Contraception, 33, pp. 533-538, (1986)

[10]

Genazzani A.R., Petraglia F., Parrini D., Nasi A., Angioni G., Facchinetti V., Volpe A., Lack of correlation between amniotic fluid and maternal plasma contents of β-lipotropin and adrenocorticotropic hormone in normal and pathologic pregnancies, Am. J. Obstet. Gynecol., 148, pp. 198-202, (1984)

← 1 2 →